Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:18   Issue: 6
Pp: 513-513
Franco Patrone
DOI: 10.2174/156800961806180611103149
Published on: 11 June, 2018



Tunneling Nanotubes: A Versatile Target for Cancer Therapy

Volume:18   Issue: 6
Pp: 514-521
Pragyaparamita Sahu, Soumya Ranjan Jena and Luna Samanta*
DOI: 10.2174/1568009618666171129222637
Published on: 11 June, 2018




Towards Prevention of Ovarian Cancer

Volume:18   Issue: 6
Pp: 522-537
Aus Tariq Ali*
DOI: 10.2174/1568009618666180102103008
Published on: 11 June, 2018




Oxidative Stress and Cancer: The Role of Nrf2

Volume:18   Issue: 6
Pp: 538-557
Soraya Sajadimajd and Mozafar Khazaei*
DOI: 10.2174/1568009617666171002144228
Published on: 11 June, 2018




Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy

Volume:18   Issue: 6
Pp: 558-566
Jie Wu, Dingxin Di, Chen Zhao, Yingyi Liu, Hongxia Chen, Yan Gong, Xianda Zhao and Honglei Chen*
DOI: 10.2174/1568009618666171129223533
Published on: 11 June, 2018




Fertility Drugs and Ovarian Cancer

Volume:18   Issue: 6
Pp: 567-576
Aus Tariq Ali*
DOI: 10.2174/1568009617666170620102049
Published on: 11 June, 2018




Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells

Volume:18   Issue: 6
Pp: 577-591
Tiantian Zhang, Dennis H. Kordish, Yogesh R. Suryawanshi, Rob R. Eversole, Steven Kohler, Charles D. Mackenzie and Karim Essani*
DOI: 10.2174/1568009617666170630143931
Published on: 11 June, 2018




Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling

Volume:18   Issue: 6
Pp: 592-599
Xinhua Xie, Xiaojia Huang, Hailin Tang, Feng Ye, Lu Yang, Xiaofang Guo, Zhi Tian, Xiaofang Xie, Cheng Peng* and Xiaoming Xie*
DOI: 10.2174/1568009617666171024165657
Published on: 11 June, 2018




CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Volume:18   Issue: 6
Pp: 608-616
Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, Alessandro Casellato, Paolo Macaccaro, Laura Quotti Tubi, Andrea Visentin, Livio Trentin, Gianpietro Semenzato and Francesco Piazza*
DOI: 10.2174/1568009617666170427110450
Published on: 11 June, 2018